Johnson & Johnson To Pay More Than $1.6 Billion To Resolve Healthcare Fraud Allegations

Monday, November 04, 2013

Tennessee will receive more than $12 million as part of a multistate and federal agreement resolving allegations pharmaceutical manufacturer Johnson & Johnson and its subsidiary, Janssen Pharmaceuticals, Inc., used deceptive marketing tactics. Specifically, the parties will pay $1.6 billion to resolve civil and criminal allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega. 

J&J and Janssen will pay in excess of $1.2 billion to the states and the federal government to resolve four qui tam, or whistleblower, lawsuits filed in the U.S. District Court for the Eastern District of Pennsylvania under the provisions of the federal False Claims Act and similar state False Claims statutes. In addition, Janssen Pharmaceuticals, Inc. will plead guilty in federal court to a criminal misdemeanor charge of misbranding Risperdal in violation of the Food, Drug, and Cosmetic Act.  As part of the criminal plea, Janssen has agreed to pay an additional $400 million in criminal fines and forfeitures.

“We applaud the cooperative work of the states and federal government to stop drug companies from illegally marketing potentially dangerous drugs to the public,” Tennessee Attorney General Bob Cooper said.  “The public needs to be able to trust those responsible for their health and well-being, and that includes drug manufacturers and those who prescribe medications.” 

J & J and Janssen allegedly promoted, marketed and introduced Risperdal and Invega into interstate commerce for uses not approved by the Food and Drug Administration and for uses that were not medically indicated.  Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote a drug for an “off-label” or other use not identified in the FDA-approved product label.  The states contend that during the period Jan. 1, 1999 through Dec. 31, 2005, the companies promoted Risperdal for off-label uses and made false and misleading statements about the safety and efficacy of Risperdal.

The states additionally allege J&J and Janssen paid illegal kickbacks to health care professionals and long-term care pharmacy providers to induce them to promote or prescribe Risperdal to children, adolescents and the elderly when there was no FDA approval for Risperdal use in these patient populations. The states further contend that from Jan. 1, 2007 through Dec. 31, 2009, the companies promoted Invega for off-label uses and made false and misleading statements about the safety and efficacy of Invega.  The manufacturers’ alleged unlawful conduct caused false and/or fraudulent claims to be submitted to or caused purchases by government funded health care programs, including the state Medicaid programs. 

As part of the global resolution, the companies will enter into a Corporate Integrity Agreement with the U.S. Department of Health and Human Services, Office of the Inspector General, which will monitor the company’s future marketing practices.

A team from the National Association of Medicaid Fraud Control Units worked with the federal government on the investigation and conducted the settlement negotiations with the pharmaceutical manufacturers on behalf of the states.  Team members included representatives from the Offices of the Attorneys General for the states of New York, Massachusetts, Ohio and California.

Hutcheson Awarded Hospital Accreditation From The Joint Commission

Hutcheson Medical Center on Monday announced that it has earned The Joint Commission’s Gold Seal of Approval for Hospital Accreditation by demonstrating continuous compliance with its performance standards. The Gold Seal of Approval is a symbol of quality that reflects an organization’s commitment to providing safe and effective patient care.  Hutcheson underwent ... (click for more)

Love's Travel Stops Raises Money For Children's Hospital

Love’s Travel Stops team members and customers raised more than $14,900 during Love’s annual fundraising campaign for Children’s Hospital at Erlanger, a member of Children’s Miracle Network Hospitals.   Employees invited customers to purchase a $1, $5 or $20 Miracle Balloon at the register during the recent month-long fundraising campaign, Put the Money Where the Miracles ... (click for more)

Erlanger Refinancing To Provide Cash For New Children's/Women's Hospital, $50 Million Erlanger East Expansion, $8.5 Million Surgical Improvements

Erlanger Health System officials said an overhaul of the hospital's debt will include $70 million in new loans for several major hospital projects - including $11.5 million toward a new $30 million Children's/Women's Hospital. The overall cost of the latter facility is $30 million, but the hospital is seeking significant outside gifts and support. It will also pay for a $50 million ... (click for more)

Legendary Radio Broadcaster Luther Dies At 92 After Record 74 Years On The Air; Funeral Will Be Thursday At 2 PM At Engel Stadium

Legendary radio broadcaster Luther Masingill died early Monday morning at Memorial Hospital surrounded by family and friends. He was 92 and had been on the air for a record 74 years. Funeral services will be held on Thursday at Historic Engel Stadium, 1130 E 3rd St., at 2 p.m. with Pastor Todd McElyea officiating.   Honorary pallbearers will be the staff at ... (click for more)

Chattanooga Has Lost Its Most Popular Citizen - Luther Masingill

Chattanooga has lost its most popular citizen – Luther Masingill. Although we are saddened we cherish the memories.  All of us have a Luther story.  Mine is the first time I met Luther.  This was before TV and all of Chattanooga listened to Luther on the radio.  I was 12-years-old.  Some of my buddies and I had gone to the State Theater in downtown ... (click for more)

Roy Exum: An Election Day Fable

Every day I am peppered with emails that friends send to me from across the country so I am unsure of where the fable you are about to read originated. But with early voting for the November general election now in full swing, I think everyone who will -- or will not -- take part in freedom’s greatest privilege should read this story because I believe there is a great lesson contained ... (click for more)